Global Gonorrhea Testing Market Size, Trends, and Growth Opportunity, By Test Type (Nucleic Acid Amplification, Gram Stain, Enzyme-linked Immunosorbent Assay, Gonorrhea Culture, and Rapid Test), By Sample Type (Blood, Lymph Fluid, Urine, Throat Swab, and Penis/Vaginal Swab), By End-User (Hospitals, Pathology Labs, and Point of Care Testing), By Region and Forecast to 2030.
Global Gonorrhea Testing Market
The Global Gonorrhea Testing Market was valued at USD 8.25 billion in 2022 and is expected to expand to USD 16.65 billion by 2030, at a CAGR of 8.06% during the forecast period 2023-2030.
Gonorrhea is a sexually transmitted infection, also known as an STD (sexually transmitted disease). It is caused by a bacterium that infects both males & females. Gonorrhea most often affects the urethra, rectum & throat. Mostly in females, gonorrhea can also infect the cervix.
Gonorrhea is most spread during vaginal, oral, or anal sex. But babies of infected mothers may be infected during childbirth. In toddlers, gonorrhea most commonly affects the eyes.
Market Drivers
The increase in the growth rate of STDs demands rapid use of gonorrhea testing. As per the data of 2022, WHO, more than 1 million sexually transmitted infections (STI) are acquired worldwide every single day; most of them will be asymptomatic. It also specified that about 375 million new infections are yearly, with 1 out of 4 STIs such as gonorrhea, trichomoniasis, syphilis, and chlamydia. These diseases demand immediate testing to detect the virus for faster treatment. Thus, this factor boosts the global gonorrhea testing market growth.
Furthermore, the increasing feasibility of various testing methods and growing government awareness of gonorrhea testing is boosting the market further.
Market Restraints
Most of the gonorrhea tests available to detect infection typically need laboratory facilities, which tends to be a very costly process. Several tools, such as cell culture & microscopy, are highly sensitive and need technical control and management. These factors negatively impact the gonorrhea testing industry's growth.
Market Segmentation
The global gonorrhea testing market is segmented into test type, sample type, end-user, and region.
Based on test type, the global gonorrhea testing market is segmented into nucleic acid amplification, gram stain, enzyme-linked immunosorbent assay, gonorrhea culture, and rapid test.
Further, based on end-user, the global gonorrhea testing market is segmented into hospitals, pathology labs, and point-of-care testing.
Regional Analysis
The global gonorrhea testing market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the gonorrhea testing market owing to many care tests and high awareness among people associated with STIs. Also, the wide availability of FDA-approved STI disease testing devices enhance the market growth in the region.
The Asia-Pacific region is expected to witness a significant CAGR growth rate due to rising health awareness. The growing prevalence of STIs in underdeveloped economies and the economic growth in these regions lead to market growth.
Key Players
Various key players are discussed in the global gonorrhea testing market report including; Abbott Laboratories, Bayer AG, Merck and Company Inc., Agilent Technologies, Biomerieux, Danaher Corporation, Thermo Fisher Scientific, Alere Inc., DiaSorin, Bristol-Myers Squibb, F. Hoffmann-La Roche AG, and Others.
For instance, in August 2020, The United States National Institutes of Health (USNIH) announced that a diagnostic test for detecting Neisseria gonorrhoeae by Visby Medical won the USD 19 million Antimicrobial Resistance Diagnostic Challenge.
Market Taxonomy
By Test Type
• Nucleic Acid Amplification
• Gram Stain
• Enzyme-linked Immunosorbent Assay
• Gonorrhea Culture
• Rapid Test
By Sample Type
• Blood
• Lymph Fluid
• Urine
• Throat Swab
• Penis/Vaginal Swab
By End-User
• Hospitals
• Pathology Labs
• Point of Care Testing
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Gonorrhea Testing Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Gonorrhea Testing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact Due To Recent Energy Crisis
4.2.5 Cumulative Impact Due Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact Of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Gonorrhea Testing Market, By Test Type
5.1 Y-o-Y Growth Comparison, By Test Type
5.2 Global Gonorrhea Testing Market Share Analysis, By Test Type
5.3 Global Gonorrhea Testing Market Size and Forecast, By Test Type
5.3.1 Nucleic Acid Amplification
5.3.2 Gram Stain
5.3.3 Enzyme-linked Immunosorbent Assay
5.3.4 Gonorrhea Culture
5.3.5 Rapid Test
6 Global Gonorrhea Testing Market, By Sample Type
6.1 Y-o-Y Growth Comparison, By Sample Type
6.2 Global Gonorrhea Testing Market Share Analysis, By Sample Type
6.3 Global Gonorrhea Testing Market Size and Forecast, By Sample Type
6.3.1 Blood
6.3.2 Lymph Fluid
6.3.3 Urine
6.3.4 Throat Swab
6.3.5 Penis/Vaginal Swab
7 Global Gonorrhea Testing Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Gonorrhea Testing Market Share Analysis, By End User
7.3 Global Gonorrhea Testing Market Size and Forecast, By End User
7.3.1 Hospitals
7.3.2 Pathology Labs
7.3.3 Point of Care Testing
7.3.4 Others
8 Global Gonorrhea Testing Market, By Region
8.1 Global Gonorrhea Testing Market Share Analysis, By Region
8.2 Global Gonorrhea Testing Market Share Analysis, By Region
8.3 Global Gonorrhea Testing Market Size and Forecast, By Region
9 North America Gonorrhea Testing Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Gonorrhea Testing Market Share Analysis, By Test Type
9.3 North America Gonorrhea Testing Market Share Analysis, By Sample Type
9.4 North America Gonorrhea Testing Market Size and Forecast, By End User
9.5 North America Gonorrhea Testing Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Gonorrhea Testing Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Gonorrhea Testing Market Share Analysis, By Test Type
10.3 Europe Gonorrhea Testing Market Share Analysis, By Sample Type
10.4 Europe Gonorrhea Testing Market Size and Forecast, By End User
10.5 Europe Gonorrhea Testing Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Gonorrhea Testing Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Gonorrhea Testing Market Share Analysis, By Test Type
11.3 Asia Pacific Gonorrhea Testing Market Share Analysis, By Sample Type
11.4 Asia Pacific Gonorrhea Testing Market Size and Forecast, By End User
11.5 Asia Pacific Gonorrhea Testing Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Gonorrhea Testing Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Gonorrhea Testing Market Share Analysis, By Test Type
12.3 Latin America Gonorrhea Testing Market Share Analysis, By Sample Type
12.4 Latin America Gonorrhea Testing Market Size and Forecast, By End User
12.5 Latin America Gonorrhea Testing Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Gonorrhea Testing Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Gonorrhea Testing Market Share Analysis, By Test Type
13.3 Middle East Gonorrhea Testing Market Share Analysis, By Sample Type
13.4 Middle East Gonorrhea Testing Market Size and Forecast, By End User
13.5 Middle East Gonorrhea Testing Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market Share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Abbott Laboratories
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Bayer AG
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.25 Key Market Developments
15.2.6 Key Strategies
15.3 Merck and Company Inc.
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Agilent Technologies
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Biomerieux
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Danaher Corporation
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Thermo Fisher Scientific
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Alere Inc.
15. 8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 DiaSorin
15.9.1 Overview
15.9.2 Offerings
15.4.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Bristol-Myers Squibb
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
